FDA Inspection 1162005 — Andres F. Camacho-Gonzalez, M.D.
The FDA completed an inspection of Andres F. Camacho-Gonzalez, M.D. on February 4, 2022 in Atlanta, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- February 4, 2022
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Atlanta, GA (United States)
Additional Details
Clinical BA/BE